RXRX
Recursion Pharmaceuticals, Inc.
$2.83+0.11 (+3.86%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Apr 16, 2021 – Nov 18, 2026, Dividends reinvested
- Final balance
- $903
- CAGR
- −34.96%
- Max drawdown
- −93.42%
Trailing returns (%)
RXRX's average annual return was −31.86% over the last 5 years, through Nov 18, 2026. $10,000 in RXRX on Nov 18, 2021 fell to $1,469 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- −18.47%
- 3M
- −8.58%
- 6M
- −2.25%
- YTD
- −30.93%
- 1Y
- −32.09%
Per year
- 3Y
- −26.28%
- 5Y
- −31.86%
- Since 2021
- −34.96%
Annual returns
2021 from Apr 16 · 2026 through Nov 18
RXRX returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | −30.93% |
| 2025 | −39.50% |
| 2024 | −31.44% |
| 2023 | +27.89% |
| 2022 | −54.99% |
| 2021 from Apr 16 | −45.27% |
Metrics
Since 2021| Volatility | 93.01% |
|---|---|
| Sharpe ratio | −0.02 |
| Sortino ratio | −0.03 |
| Calmar ratio | −0.37 |
| Longest drawdown | 5.3 years |
Worst drawdowns
Since 2021| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −93.4% | Jul 2021 | Nov 2026 | Not yet | 5.3 years so far |
| −38.1% | Apr 2021 | May 2021 | Jun 2021 | 2 months |
| −10.5% | Apr 2021 | Apr 2021 | Apr 2021 | 5 days |
| −10.4% | Jun 2021 | Jun 2021 | Jul 2021 | 2 weeks |
| −8.3% | Apr 2021 | Apr 2021 | Apr 2021 | 1 week |